cimb-logo

Journal Browser

Journal Browser

Announcements

5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

2024 Annual Meeting – Beijing (15 January 2025)

You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.

Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.

This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.

I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.

“Our editorial teams represent MDPI at its finest”

I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.

Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.

MDPI Offices in China

While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:

  • 2008: Beijing (Tongzhou, Haidian)
  • 2013: Wuhan (Hankou, Guanggu)
  • 2019: Tianjin
  • 2021: Dalian
  • 2021: Nanjing

To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.

While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.

We look forward to a year filled with continued collaboration, growth, and shared success.

“We remain committed to future growth in China”

Impactful Research

MDPI and Jisc Consortium Extend Open Access Agreement for 2025

I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.

Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.

Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.

A full list of participating institutions can be found here.

As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”

At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.

Inside MDPI

Visit to MDPI's Singapore office

During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.

Welcoming and Supporting New Team Members

“Experienced staff play an important role in mentoring new hires”

I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.

Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.

Building MDPI’s Positive Reputation

During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.

Connecting with the Singapore Marketing Team

I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow. 

During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.

Meeting with Prof. Dr. Manoj Gupta

Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.

Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.

Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.

During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.

PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!

 

Coming Together for Science

JAMS – Journal & Article Management System

I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.

With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.

“JAMS is a testament to our commitment to simplifying the publishing process”

Explore the new website here: jams.pub

It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.

Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.

JAMS was built to change that by adapting to the unique requirements of each publisher.

At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.

Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.

Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

What Sets JAMS Apart?

  • Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
  • End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
  • Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
  • Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
  • Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.

Partners Who Already Trust JAMS

If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.

Closing Thoughts

Visit to MDPI's Bangkok office

To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.

I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.

Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.

Engaging with Group Leads

“Group leads play an important role in creating a safe, positive environment”

During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.

To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.

University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)

We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.

Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.

This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.

“My time in Bangkok was productive and inspiring”

My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.

Stefan Tochev
Chief Executive Officer
MDPI AG

4 February 2025
World Cancer Day 2025—United in Every Journey


Cancer impacts millions of lives worldwide, yet each person’s journey with the disease is uniquely their own. World Cancer Day reminds us that while the disease impacts individuals differently, our shared strength, innovation, and focus on holistic care bring us closer to a future where cancer no longer dictates lives. Every experience, challenge, and success story contribute to the broader fight against cancer, demonstrating the resilience and hope that unite us all. As we continue to make strides through innovative research, treatment advancements, and global collaboration, it is essential to recognize both the diversity of stories and our common goal of overcoming cancer together.

In observance of this day, we invite you to explore the following resources that delve into the field of cancer and the cutting-edge advancements shaping its care. By prioritizing people-centered treatment where patients’ voices and needs guide care, we can ensure personalized attention for all. It is our hope to foster a deeper understanding of the impact of cancer and encourage meaningful action to support patients, caregivers, and researchers in their pursuit of a world free from cancer’s hold. Together, we can inspire action and work toward a cancer-free future.

Biology & Life Sciences

Medicine & Pharmacology

Chemistry & Material Sciences

Public Health & Healthcare

Engineering

Society

Rare Variants of Dermatofibrosarcoma Protuberans: Clinical, Histologic, and Molecular Features and Diagnostic Pitfalls
by Celestine M. Trinidad, Sintawat Wangsiricharoen, Victor G. Prieto and Phyu P. Aung
Dermatopathology 2023, 10(1), 54–62; https://doi.org/10.3390/dermatopathology10010008

Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective
by Adarsh Kumar, Ankit Kumar Singh, Harshwardhan Singh, Veena Vijayan, Deepak Kumar, Jashwanth Naik, Suresh Thareja, Jagat Pal Yadav, Prateek Pathak, Maria Grishina et al.
Pharmaceuticals 2023, 16(2), 299; https://doi.org/10.3390/ph16020299

Artificial Intelligence in Brain Tumor Imaging: A Step toward Personalized Medicine
by Maurizio Cè, Giovanni Irmici, Chiara Foschini, Giulia Maria Danesini, Lydia Viviana Falsitta, Maria Lina Serio, Andrea Fontana, Carlo Martinenghi, Giancarlo Oliva and Michaela Cellina
Curr. Oncol. 2023, 30(3), 2673–2701; https://doi.org/10.3390/curroncol30030203

Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook
by Onyinyechi Obidiro, Gantumur Battogtokh and Emmanuel O. Akala
Pharmaceutics 2023, 15(7), 1796; https://doi.org/10.3390/pharmaceutics15071796

Biomarkers in Breast Cancer: An Old Story with a New End
by Lyvia Neves Rebello Alves, Débora Dummer Meira, Luiza Poppe Merigueti, Matheus Correia Casotti, Diego do Prado Ventorim, Jucimara Ferreira Figueiredo Almeida, Valdemir Pereira de Sousa, Marllon Cindra Sant’Ana, Rahna Gonçalves Coutinho da Cruz, Luana Santos Louro et al.
Genes 2023, 14(7), 1364; https://doi.org/10.3390/genes14071364

Could Microbiome Be the Common Co-Denominator between Type 2 Diabetes and Pancreatic Cancer?
by Marin Golčić and Andrej Belančić
Diabetology 2023, 4(4), 553–559; https://doi.org/10.3390/diabetology4040049

Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers
by Ravi Bharadwaj, Swati Jaiswal, Erandi E. Velarde de la Cruz and Ritesh P. Thakare
Diseases 2024, 12(3), 63; https://doi.org/10.3390/diseases12030063

Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer
by Dimitrios Stefanoudakis, Maximos Frountzas, Dimitrios Schizas, Nikolaos V. Michalopoulos, Alexandra Drakaki and Konstantinos G. Toutouzas
Curr. Issues Mol. Biol. 2024, 46(4), 2827–2844; https://doi.org/10.3390/cimb46040177

Metformin: From Diabetes to Cancer—Unveiling Molecular Mechanisms and Therapeutic Strategies
by Emilia Amengual-Cladera, Pere Miquel Morla-Barcelo, Andrea Morán-Costoya, Jorge Sastre-Serra, Daniel Gabriel Pons, Adamo Valle, Pilar Roca and Mercedes Nadal-Serrano
Biology 2024, 13(5), 302; https://doi.org/10.3390/biology13050302

Immune Checkpoint Inhibitors: Fundamental Mechanisms, Current Status and Future Directions
by Abdullah Younis and John Gribben
Immuno 2024, 4(3), 186–210; https://doi.org/10.3390/immuno4030013

Breast Cancer Screening among African Immigrants in the United States: An Integrative Review of Barriers, Facilitators, and Interventions
by Julian I. Rauch, Joseph Daniels, Alyssa Robillard and Rodney P. Joseph
Int. J. Environ. Res. Public Health 2024, 21(8), 1004; https://doi.org/10.3390/ijerph21081004

Predicting Leukoplakia and Oral Squamous Cell Carcinoma Using Interpretable Machine Learning: A Retrospective Analysis
by Salem Shamsul Alam, Saif Ahmed, Taseef Hasan Farook and James Dudley
Oral 2024, 4(3), 386–404; https://doi.org/10.3390/oral4030032

Comprehensive Treatment of Rectal Cancer

Mental Health and Nursing Care of Individuals with Cancer and Their Families—2nd Edition

New Advances in Community-Based Approaches to Cancer Prevention Epidemiology

Cancer Immunotherapy and the PD-1/PD-L1 Checkpoint Pathway

Novel, Low Cost Technologies for Cancer Diagnostics and Therapeutics

Metabolic Reprogramming in Cancer: New Frontiers for Therapeutic Intervention

Pulmonary Fibrosis and Lung Cancer: Pathophysiology and Novel Therapeutic Approaches

 

21 January 2025
MDPI’s Newly Launched Journals in December 2024

Nine new journals covering multiple subjects launched their inaugural issues in December 2024. We are excited to be able to share with you the newest research rooted in the value of open access.

We would like to express our deepest appreciation to all of the Editorial Board Members, and each journal will ensure its high-quality output by using excellent editorial and rigorous peer-review processes, to ensure that the articles achieve high impact and visibility.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)


Prof. Dr. Zhaoyang Dong
City University of Hong Kong, China
Editorial | View inaugural issue

energy storage technologies; energy storage system management; energy storage applications; strategies in renewable energy generation grid integration; distributed storage systems; economics and markets for energy storage
View journal scope | Submit an article

Prof. Dr. Yang-Hui He
1. London Institute for Mathematical Sciences, Royal Institution, UK
2. University of Oxford, UK
Editorial | View inaugural issue
Euclidean geometry; differential geometry; algebraic geometry; complex geometry; discrete geometry; computational geometry; geometric group theory;  convex geometry
View journal scope | Submit an article

Dr. Michel Planat
Université de Franche-Comté, France
Editorial | View inaugural issue
differential topology; algebraic topology; manifold topology; homology theory; low-dimensional topology; fuzzy sets
View journal scope | Submit an article

Prof. Dr. Rashid Al Abri
1. Sultan Qaboos University, Oman
2. Oman Medical Association, Oman
Editorial | View inaugural issue
clinical practices as well as research and innovation in medical education, risk management in healthcare, and patient safety
View journal scope | Submit an article

Prof. Dr. Ecevit Bilgili*
New Jersey Institute of Technology, USA
*Prof. Dr. Ecevit Bilgili passed away before the completion of the inaugural issue. His dedication and vision for JPBI will always be remembered and serve as a guiding inspiration.
Editorial | View inaugural issue
early drug discovery and development; product characterization and pre-clinical testing; drug delivery systems and drug design; active pharmaceutical ingredient (API) production
View journal scope | Submit an article

Dr. Weiyong Liu
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
theories, methodologies, technologies, and applications in the fields of laboratory medicine and clinical chemistry
View journal scope | Submit an article

Prof. Dr. Manuel Pedro Rodríguez Bolívar
University of Granada, Spain
Editorial | View inaugural issue
scientometrics; informetrics; bibliometrics; altmetrics; webometrics; research evaluation
View journal scope | Submit an article

Prof. Dr. Fei Fan
Wuhan University, Wuhan 430072, China
Editorial | View inaugural issue
regional growth theory and methods; regional system modeling and optimization; regional development policy; regional spatial evolution; environmental policy and instrument choice
View journal scope | Submit an article

Dr. Kevin Cianfaglione
Université Catholique de Lille, France
Editorial | View inaugural issue
wild species and their habitats; wild environments and biodiversity; natural environment management; wild land preservation
View journal scope | Submit an article

We wish to thank everyone who has supported the development of open access publishing. You are welcome to send an application here, or contact the New Journal Committee (newjournal-committee@mdpi.com) if you would like to create more new journals.

20 January 2025
Acknowledgment to the Reviewers of Current Issues in Molecular Biology in 2024


The editorial team at Current Issues in Molecular Biology extends our heartfelt thanks to the dedicated reviewers whose expertise and commitment have been key to the journal's success in 2024. Last year, Current Issues in Molecular Biology received 4273 review reports from 2468 reviewers representing 75 countries and regions worldwide.

To recognize the invaluable time, effort, and attention to detail that each reviewer dedicates, Current Issues in Molecular Biology expresses its sincere gratitude through an annual acknowledgment of reviewers. As a further token of appreciation, all reviewers are eligible for the Outstanding Reviewer Award, which honors their essential role in enhancing the quality of our publications.

We are honored to recognize the reviewers who allowed us to publish their names each year. The names of these reviewers are listed below in alphabetical order by first name:

A. Guillermo Bracamonte Hana Rauchová Natalia Paramonova
A. N. M. Mamun-Or-Rashid Hang Cheng Neeraj Kumar Chauhan
Abhishek Dey Hanqi Yang Neli Milenova Vilhelmova-Ilieva
Abraham Wall-Medrano Hanwei Jiao Neus Baena
Adam Matkowski Hao Wu Nicholas Geraghty
Adam Whisnant Haomin Liu Nicholas J. Bradshaw
Adham Sleem Harindranath Kadavath Nicola Marziliano
Aditya Yashwant Sarode Harris Pratsinis Nicolás O. Soto-Cruz
Adnan Alahmadi Heba Abd Elghany Sahyon Nicolas Torres
Adriana Cristina Urcan Hebat-Allah S. Tohamy Nicoleta Radu
Adriana De Cássia Ortiz Héctor Mora-Montes Nicoletta Cera
Afaf El-Ansary Hee-Geun Jo Nina Filip
Agata Makowska Helder C. R. Oliveira Nithyananthan Subramaniyam
Agnieszka Krakowiak Henrique Silva Nompumelelo Mkhwanazi
Agnieszka Potęga Henry G. Kaplan Norbert Nass
Agnieszka Szewczyk Herman J. Woerdenbag Normand García-Hernández
Agustin Maceda Hexiao Wang Nuno M. S. Almeida
Ahmed Darwish Hidehisa Shimizu Oleksii Skorokhod
Ahmed E. Noreldin Hipolito Nzwalo Oliver Baum
Ahmed Elfana Hiroki Kittaka Olivier Micheau
Ahmed El-Fiqi Hiroyuki Kataoka Omar M. Ibrahim
Ahmed Mohamed Helmi Hiroyuki Noda Osama A. Elkashty
Aislan Carvalho Vivarini Hisao Haniu Osama A. Saeed
Aiying Yu Hoda Ibrahim Oscar Campuzano
Akihiko Murayama Ho-Jin Lee Oscar E. Cigarroa-Mayorga
Alarico Ariani Hong Yang Otávio Augusto Chaves
Alberto Marra Hongbo Zheng Oxana Kazakova
Alejandra García-Gasca Hossam Ramadan El-Sherbiny Pablo Andrei Nogara
Alejandro Casas-Alvarado Houshang Nemati Pablo Daniel Vallecorsa
Alessandra Renzini Hsinjung Ho Padmanabhan Mahadevan
Alessio Ardizzone Huai Deng Panagiotis Mallis
Alexander Baykov Husam Qanash Panagiotis Simitzis
Alexander E. Berezin Hyun-Min Kim Parisa Gazerani
Alexandra Ban-Cucerzan Iasonas Dermitzakis Parul Singh
Alexandru Dan Costache Ibrahim Bello Pasquale Marrazzo
Alexandru Vasincu I-Jen Wang Patrícia C. Pires
Alexandru Vlasa Ikeotunye Royal Chinyere Pedro Catalão Moura
Alexey Pshezhetsky Iliyan Ivanov Pei Wang
Alexis Murillo Carrasco Iliyana Kirilova Rasheva Peilin Liu
Alexis Stamatikos Imran Ali Peter Lunt
Alfonso Baldi Imran Khan Peter Piko
Alicja Kluczyk Ina Sevic Peter Viktor Hauser
Alireza Mansouri Inah Gu Piero Antonio Zecca
Alireza Shoari Ines Kovačić Pierre Betu Kasangana
Almerinda Agrelli Ioan Grozescu Pietro Cacialli
Álvaro López Zaplana Ioan Hutu Pinaki Bhattacharjee
Amany Elshenawy Ioannis Ilias Pinelopi Vlotinou
Amit S. Chougule Ioannis Roussis Ping-Hsiu Huang
Amol Balasaheb Mhetre Ion Brinza Plamena Marinova
Ana Lemus-Conejo Irena Ilic Po-An Chen
Ana Sofia Vallés Irena Nalepa Polina Perelman
Ana Vrsalović-Presečki Isabel Marques Prabu Paramasivam
Anastasia Malakhova Isabella Panfoli Pradeep Kumar Jaiswal
Anastasios Potiris Isabella Russo Pradeep Kumar Panda
Anca Stana Istvan Zupko Pragya Tiwari
André Baby Itamar Luís Gonçalves Prakash B. Adhikari
André Pereira Ivan Semenyuta Prashant Tarale
Andrea Ambrosini-Spaltro Ivan Šoša Pratap Basim
Andrea Bianconi Ivan Stoikov Preteesh Leo Mylabathula
Andrea Frosolini Ivana Škrlec Pushpa Joshi
Andreea D. Ona Iwona Maria Golonka Qing-Wei Chen
Andreia Pereira Matos J Francis Borgio Qudisa Saeed
Andrey Markov Jake Harold Pensavalle Rada Jeremic
Andrey Sgibnev James C. L. Chow Radosław Kujawski
Andrzej Czyrski James Hunter Radu Ciprian Racovita
Ángel Arturo López González James P. Bennett, Jr. Ragaa Hamouda
Ángel Juan García Yagüe James W. Navalta Raghu Ramanathan
Angelina Rosiak Jaromir Myslivecek Rahul Babubhai Chaudhari
Angelos K. Sikalidis Jayanta Kumar Patra Rajith Varman Seshappa Venkatesan
Àngels González-Lafont Jean-Marc Zingg Rakesh Srivastava
Anikó Bozsik Jelena Rakocevic Raluca Nicu
Anna Furlan Jelena Roganovic Ramón A. González
Anna Kasprzyk Jelica Grujic-Milanovic Ranjeet Kumar
Anna Lauritano Jerry Malayer Raquel Castillo
Anna Luiza R. Facchetti V. Assumpcao Jerzy Bełtowski Rashim Singh
Anna Makuch-Kocka Jerzy Tadeusz Chudek Rashmi Gupta
Anna Sannino Jianing Xi Raúl Cuauhtémoc Baptista Rosas
Anna Szczerba-Turek Jianzhao Qi Raul Díaz
Anthony Alfred Gaspari Jidan Ye Raveendar Sebastin
Anton Kiselev Jieshi Yu Ravi Chidambaram
Antonio Casado Díaz Jihua Guo Ravindra Thakkar
Antonio Gidaro Jimin Han Razmik Mirzayans
Antonio Quintero Ramos Jinwei Zhang Razvan Ionescu
António Raposo Jin-Won Park Rebecca Clement
Arianna Filippelli Jitendra Pandey Remi Charrel
Arkadiusz Artyszak Joanna Rog Renáta Minorics
Arpita Shome Joao Pessoa Rene Buchet
Artur Słomka Joaquim Carreras Ricardo Coletta
Arun Kumar Rajendran John Tay Ricardo Gil-Ortiz
Arvind Negi Jonas Siaulys Richard Bright
Asaad Babker Jonatan-Jafet Uuh-Narvaez Ritthideach Yorsaeng
Asad Rehman Jonathan Puente-Rivera Robin Cooper
Asdrubal Aguilera-Méndez Jong-Eun Kim Rocio Nuñez-Calonge
Ashis Kumar Mondal Jorge Diogo Da Silva Rodolfo Lagunes-Quintanilla
Ashish Kabra Jorge Gutiérrez-Cuevas Rodolfo Rey
Atar Singh Kushwah José A. García-Sanz Rohit Singh
Athanasios A. Panagiotopoulos José Andrade Rohollah Nasiri
Athina Pyrpasopoulou Jose Antonio Velázquez-Aragón Romain Donne
Avram Calin Jose Francisco Sanchez-Herrero Roxana Covali
B.H. Jaswanth Gowda José López Castro Roxana Liana Lucaciu
Barbara Ciastek José Luis Villalpando-Aguilar Roxana-Maria Amarandi
Barbara Hausott Jose M. Mulet Rui Gaspar
Barbara Mognetti Jovana Rajkovic Rui Vitorino
Barbara Sawicka Juan Francisco Leon Rui Zhong
Bartłomiej Potaniec Juana Reche Rupkatha Banerjee
Basu Dev Pandey Julio Martín-Ruiz Sabyasachi Sen
Basveshwar Gawali Jun Huang Saeed Mohamadzade Namin
Beate Obermüller Jun Liu Saeedeh Ghiasvand
Beatriz Medeiros-Fonseca Juncan Anca Maria Sagar Salave
Ben De Lacy Costello Ju-Seop Kang Sam Ho
Benjamin Cartes-Saavedra Jutamat Klinsoda Samuel Pita
Benjamin Roche Kalyani Dhusia Sandra Brosda
Bhola Pradhan Kamil Nelke Sanjay Kumar Singh Patel
Bice Avallone Kao Yao Santanu Ghosh
Bin Wang Karen Bohmwald Sara Massironi
Bistra Galunska Karol Ali Apaza Alccayhuaman Sara Meirinho
Bogdan Sevastre Karolina A. Wojtunik-Kulesza Satoshi Yamasaki
Bojidarka Ivanova Karolina Anna Wodz Saurabh Chaturvedi
Boleslaw T. Karwowski Karthikeyan Subbarayan Saurabh Jain
Brenda Anabel Lopez Ruiz Karthikeyan Thiyagarajan Seamus O'Reilly
Bruno Fionda Katalin Sipos Sebastian John Adams
Bruno Massa Katarzyna Gieczewska Sebastian Mertowski
Calin Corciova Kate Hyde Seema Kumari
Canjia Zhai Kaveh Nasiri Selvakumar Subbian
Carlos Gamarra-Luques Kay Choong See Sergei Grishin
Carmen Burtea Kazuchika Nishitsuji Sergio Gastón Caspe
Carmen Lizette Del Toro Sánchez Kazuhiko Nakadate Setondji Cocou Modeste Alexandre Yahouédéhou
Carolina Elisa Sanhueza Keigi Fujiwara Shahid Hussain Sofi
Carolyn Carr Keith Rochfort Shahzaib Ahamad
Caterina Carollo Kenta Teruya Shamaila Zafar
Cécil J. W. Meulenberg Kentaro Kato Shantanu Gupta
Cecilia Taverna Kh Ahammad Uz Zaman Shantanu Kundu
Cesar A. Rosales-Nieto Kijin Kim Sheng Ying
Chanakha K Navaratnarajah Kilsoo Kim Shih-Heng Chen
Chandra Mani Adhikari Kinga Lis Shilei Zhu
Chandru Subramani Kohji Nishimura Shimaa A. Amer
Chang Liu Koji Ichihara Shojiro Ichimata
Changeon Park Konda Mani Saravanan Shreya Paithankar
Changshan Niu Kongshu Ji Shu Yuan
Chen Zong Konrad Andrzej Szychowski Shuanglin Qin
Cheng Li Konstantinos Gardikis Shuchun Li
Chenjie Pan Konstantinos Papathanasiou Shuen-Ei Chen
Chen-Xi Li Kosuke Nishi Shushu Huang
Chenyan Wang Kotapati Kasi Viswanath Shuyue Zhan
Chieh-Chih Tsai Krisztián Frank Silin Wu
Chien-Yu Lin Krzysztof Brzezinski Silvio R. De Luka
Chih-Wei Zeng Kuan-Hui Ethan Chen Simone Brogi
Chika Saegusa Kyung-Min Kim Singh Kumar Avishek
Chris Fields Lăcrămioara Lacramioara Ionela Butnariu Sławomir Borek
Christian Tanislav Lacramioara Popa Sofia Bin
Christie Ying Kei Lung Lara Baticic Sofian Al Shboul
Christine Hellweg Laurent Dufossé Soheil Abbaspour-Ravasjani
Christos Papaneophytou Laurent Metzinger Somiranjan Ghosh
Cintia Kazuko Tokuhara Laxmikanta Khamari Songli Zhu
Cláudia S. Oliveira Lei Huang Soo-Hyun Sung
Claudio Caprari Lei Yu Sotiris Kyriakou
Claudio De Felice Lei Zhang Sourav Roy
Claudiu C. Popescu Libang Liang Sridhar Selvaraj
Clemens Leo Gögele Lihe Liu Srijit Das
Cole Peters Lilya U. Dzhemileva Srinivasu Karri
Constantin Munteanu Liming Chen Stanimir Manolov
Corneliu Tanase Ling Xiao Stanislaw Ołdziej
Crescenzio Scioscia Ling Yang Stefani Parmentier
Cristian Sandoval Lingwei Sun Stepan Dzhimak
Cristin Coman Ling-Wen Ding Stepan Gambaryan
Cristina Capatina Lipei Shao Stephen Ahenkorah
Cristina Corina Clement Liqing Zang Stephen Inbaraj
Cyril Fersing Liviu Macovei Stoyanka Atanasova Nikolova
Daan Ren Lorenzo Malatino Subir Kumar Juin
Dámaris Núñez-Gómez Luca Giacomelli Sudarshan Pant
Danial Khayatan Luca Palazzolo Sudhir Kumar Paidesetty
Daniel Meier Luciana Bordin Sulev Koks
Daniela Bencardino Lucjusz Zaprutko Süleyman Cemil Oğlak
Daniela Elena Ilie Ludmila Kazdova Sumalan Renata
Daniela Elena Serban Luigi Cappannoli Sumedha Nitin Prabhu
Daniela Giordano Luis Apaza Ticona Sumeet Uday Nayak
Daniela Meleleo Luis Eduardo Diaz Giménez Sung Hwan Ki
Daniela Opriş-Belinski Luis Enrique Cobos Puc Surbhi Chouhan
Daniela Vieira Buchaim Luis Exequiel Ibarra Sushant Covaris
Daniele Bani Luís Miguel De Aquino Moreira Svetoslav Todorov
Danijela Barić Lukasz Dobrek Swarnalatha Moparthi
Danilo Boskovic Łukasz Szeleszczuk Szilvia Kisvarga
Dario Siniscalco M. Eduviges Burrola-Barraza Szymon Sip
David E. Levin Maciej Stanisław Walędziak Tadeusz Malewski
David J. Ramsey Madhu Sudhana Saddala Tajamul Hussain
Debashis Dutta Madubuike Anyanwu Takahiro Oyama
Deepthi Ramesh Magdalena Mroczek Takahiro Sanada
Denis Babkov Magdalena Wróbel-Kwiatkowska Takumi Abe
Despoina Pantazi Mahmut Camlica Tamanash Bhattacharya
Dharambir Kashyap Mai Mostafa Tamara Lazarevic-Pasti
Diana Kata Maja Jazvinšćak Jembrek Tamás Visnovitz
Diego A. Rojas Maja Karnaš Tapan A. Patel
Diego Lopergolo Majid Esmaelizad Tarana Arman
Diego Portalanza Makoto Harada Taras P. Pasternak
Dijana Mitic Małgorzata Jarończyk Tatiana V. Rakitina
Dilip Kumar Swain Małgorzata Polz-Dacewicz Teng Ma
Dinara Khayrutdinova Manal Ali Elzoheiry Thayne Kowalski
Dipali Srivastava Manlio Vinciguerra Thi Sinh Vo
Dirceu Guilherme De Souza Ramos Manoj Kumar Yadav Thomas Greither
Dirk Geerts Mansoor-Ali Vaali-Mohammed Thomas-Gabriel Schreiner
Djenisa Rocha Manuel Díez-Alonso Ticuta Negreanu-Pirjol
Dmitry Karpov Manuel Lis Timothy Omara
Dmitry Kostyushev Mara Gagliardi Tiziana Maria Sirangelo
Domenico Pomarico Marcela Aragon Tomáš Čajka
Donatella Degl'Innocenti Marcelo Lima Brandão Tomas Koltai
Dongxia Wang Marcia Bastos Convento Tomasz Urbanowicz
Dorota Formanowicz Marcin Kurowski Tomislav Tosti
Dorota Piasecka-Kwiatkowska Marco A. Mendoza Tomohide Takaya
Douglas J. H. Shyu Marco Albano Tomohiro Chiba
Dragana Vuk Marco Antonio López-Carlos Tomoya Fujie
Dzmitry G. Shcharbin Marco Cavaco Toncho Dinev
Edgar Flores-Soto Marco Fiore Torbjörn Ledin
Edgar López López Marco Sapienza Trong-Nghia Le
Edward N. Harris Marek Roman Lipinski Tsvetelina Paunova-Krasteva
Edyta Pasicka Margarita Terentjeva Tzu-Ting Huang
Eiichi Kumamoto Maria A. Bonifacio Urmila Sehrawat
Eijiro Akasaka María Del Socorro Pina-Canseco Uroš Glavinić
Eisuke Amiya Maria Giuliana Vannucchi Ursula Panzner
Ekaterina Finkina Maria Iskra Vaibhavkumar S. Gawali
Ekaterina Yurchenko Maria Malvina Tsamouri Vajir Malek
Elena Amaricai Maria Roulia Valerio Leoni
Elena Chitoran Maria Salagianni Vasil Kostadinov Atanasov
Elena Proskurnina Maria V. Chatziathanasiadou Vasileios Periklis Papadopoulos
Eleni Mavrogonatou Mariana Chelu Veera Venkat Shivaji Rama Rao Edupuganti
Elisabeth Egholm Jacobsen Marina C. Costa Vera A. Alferova
Elisabetta Ferrara Marino Paroli Verónica Bastos
Elisabetta Schiano Mario Jug Vicente Eliezer Vega-Murillo
Elisavet Bouloumpasi Marios Papasotiriou Victor Seledtsov
Elnaz Amirahmadi Marios Spanakis Vikas Kumar Somani
Emanuele-Salvatore Scarpa Marisol Orozco-Ibarra Vikas Yadav
Emerson Venancio Maristela Oliveira Poletini Viktor V. Brygadyrenko
Emilia Severin Marko Baralic Viliana Gugleva
Emilio Bucio Marko Zoran Mladenović Vinay Kumar Sharma
Emilio Di Maria Marlene Fabiola Escobedo-Monge Vinay Shivanna
Emilio Mateev Marta Joanna Monder Vinayak Khodade
Emma Barroso Marta Karazniewicz Vincenzo Calabrese
Enrico Greco Martin Cerny Vinicius Jose Silva Osterne
Eric Huet Martina Gažarová Violeta Igna
Erika Staudacher Martina Kleber Violeta Popovici
Ernesto Calderon Martinez Martina Torricelli Vipin Chandra Kalia
Eshan Khan Marvin A. Soriano-Ursua Virayu Suthiphasilp
Essam Moustafa Marwa Omar Vladimir Burmistrov
Evangelos Liatsikos Masaru Yamaguchi Vladimir Makarov
Ewa Krawczyk Massimiliano Meli Wajdy Al-Awaida
Ewa M. Urbanska Matheus Vernet Machado Bressan Wilke Wanda Mączka
Fabiano Vieira Vilhena Matt P. Spick Waqar Shafqat
Fahad Khan Mauricio Comas-Garcia Waseem Jerjes
Faheem Shehjar Maurizio Badiani Wei-Feng Ding
Farhan Nabi Maurizio Sabbatini Weihua Yang
Fasih Ullah Haider Maxim Alexeevich Filatov Weiming Fang
Fatemeh Hajibabaie Mayank Choubey Weiwei Han
Fatin Jannus Md Abu Sayeed Wen Harold Chen
Faujiah Nurhasanah Ritonga Md Mahamud Ur Rashid Wenfang Li
Ferenc Orosz Md Sofiqul Islam Whidul Hasan
Fernando Cardona Meijuan Bai Wioletta Rozpędek-Kamińska
Fernando Mata Meng-Yao Li Wladimir Bocca Vieira De Rezende Pinto
Fernando Mendes Metodi D. Metodiev Wojciech Trybus
Fernando P. Monroy Michael A. Babich Wolf-Rainer Abraham
Francesca Persano Michael Poteser Won Kyong Cho
Francesco Tamiro Michał Zarobkiewicz Xiang-Fei Li
Francisco J. Del Castillo Michele Coviello Xiao Li Shen
Francisco J. Fernandez Michelle Yoo Xinxin Feng
Francisco José Barbas Rodrigues Miglena Nikolova Revalska Xinyu Ling
Francisco José Navarro-Triviño Miguel García-Castro Xolani H Makhoba
Francisco Les Mihalj Poŝa Xun Tang
Francisco Rivero Mihaly Mezei Xuxiang Liu
Frane Paic Mikko Laukkanen Yanqiang Li
Frank Guzman Mi-Kyoung Jun Yaoxiang Li
Fulin Ma Milad Shirvaliloo Yeong-Min Yoo
Gabriela Ciavoi Milan Toma Yi Yang
Gabriela Iancu Min Deng Yi-Fan Tao
Gabriela Lopes Gama Mirko Aldè Yim Tong Savio Szeto
Gaëtan Guignard Mirko Vanzan Yimin Yan
Gaetano Licata Mithun Santra Yina Wang
Gebremeskel Mamu Werid Mohamed A. Hassan Yingxue Zhang
Geetika Kaur Mohamed Gomaa Yiwei Zhou
George Sangster Mohamed Hussein Hamdy Roby Yogesh Narkhede
Gerald Henry Lushington Mohamed Mohamed Kamara Yongjun Shu
Gergana Zahmanova Mohamed Rafiullah Yongmo Wang
Gerrick E. Lindberg Mohamed Said Abbas Yongpeng Guo
Gheorghe Solcan Mohammad Hasanain Yoshiaki Sato
Giacomo Bianchi Mohanakrishnan Sathyamoorthy Youakim Saliba
Gianmarco Ferrara Mohit Chawla Yuanxiang Li
Gilberto Castañeda-Hernandez Monique F. Stins Yung-Hsiang Chen
Giovanni Levi Moon Ley Tung Yutian Ma
Girish Kumar Srivastava Mostafa Mabrouk Yutian Zou
Giuseppe Consorti Mourad Ouhammou Yves Combarnous
Giuseppe Di Martino Muhammad Afzal Zacharias Papadakis
Glustein Pozo‐Molina Muhammad Awais Farooqi Zahra Khosrowpour
Goran Augustin Muhammad Munir Zaira Kharaeva
Gordana Kovacevic Muhammad Zubair Akram Zeenat Mirza
Gourav Chandan Mustafa Al-Zamil Zhengchang Wu
Gregory Ching Nadeem Ullah Zhengwei Huang
Grigorios G. Dimas Nadezhda S. Dyrkheeva Zhibo Ma
Guang Huang Nagendraprabhu Ponnuraj Zhichao Tang
Guido H. Falduto Naman Vatsa Zhidong Zhou
Guoyou Zhang Narasimha S. Lakka Zhiyuan Yang
Hai Chi Narayanaswamy Venketasubramanian Zhong Jian
Haitham Abo-Al-Ela Naser Alsharairi Zoltan Herold
Haitham Eldoumani Natale Calomino Zorica Cvetković
Hala Badr Khalil Natalia Cheshenko  
Halina Tkaczenko Natalia Osinovskaya  

17 January 2025
Meet Us at the 145th Annual Meeting of the Pharmaceutical Society of Japan, 26–29 March 2025, Fukuoka, Japan


Conference:
The 145th Annual Meeting of the Pharmaceutical Society of Japan
Date: 26–29 March 2025
Location: Fukuoka, Japan

MDPI will be attending the 145th Annual Meeting of the Pharmaceutical Society of Japan as an exhibitor, which will be held from 26 to 29 March 2025, and we welcome researchers from diverse backgrounds to visit and share their latest ideas with us.

The conference is organized by the Pharmaceutical Society of Japan and chaired by Prof. Takashi Ohshima from the Graduate School of Pharmaceutical Sciences, Kyushu University. The theme is Promoting the Ecosystem in Pharmaceutical Sciences: Future Innovation through Cross-disciplinary Collaboration. This conference will bring together around 5,000 scientists and students to share research advances covering a wide range of scientific topics. The sessions include, but are not limited to, the following: 1) Pharmaceutical Chemistry; 2) Pharmaceutical Physics; 3) Pharmaceutical Biology; 4) Pharmaceutical Health Science and Environmental Toxicology; 5) Pharmaceutical Health Care and Sciences; and 6) Others.

The following MDPI journals will be represented at the conference:

  • Biomedicines
  • Pharmaceuticals
  • Pharmaceutics
  • Antibiotics
  • Antibodies
  • Antioxidants
  • CIMB
  • Diseases
  • Future Pharmacology
  • IJERPH
  • IJMS
  • IJTM
  • JNT
  • JPM
  • Marine Drugs
  • Medicina
  • Medicines
  • Metabolites
  • Psychoactives
  • Sci. Pharm
  • Sclerosis

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://pub.confit.atlas.jp/en/event/pharm145.

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

2 January 2025
Meet Us at the 58th European Human Genetics Conference (ESHG 2025), 24–27 May 2025, Milan, Italy


Conference: The 58th European Human Genetics Conference (ESHG 2025)
Organization: European Society of Clinical Microbiology and Infectious Diseases
Date: 24–27 May 2025
Place: Milan, Italy
Booth: #244

MDPI journals will be attending ESHG 2025 as an exhibitor. This meeting will be held in Milan, Italy, from 24 to 27 May 2025.

The significant achievements in the field of human genetics during the last few years are changing not only our understanding of genetics of diseases but also our research approaches and daily work in the clinic. Due to these new developments and insights, the traditional borders between clinical genetics, cytogenetics and molecular genetics as well as between research into monogenic and complex disorders are becoming less defined. The Scientific Programme Committee (SPC) of the ESHG decided to reflect these changes in its updated abstract submission categories and discuss those results during the conference.

The following MDPI journals will be represented:

If you plan on attending this conference, feel free to stop by our booth #244. Our delegates look forward to meeting you in person to answer any questions you may have.

For more information about the conference, please visit the following link: https://2025.eshg.org/.

25 December 2024
Meet Us at the 17th European Conference on Fungal Genetics (ECFG17), 2–5 March 2025, Dublin, Ireland


Conference: 17th European Conference on Fungal Genetics (ECFG17)
Place: Convention Centre Dublin, Ireland
Date: 2–5 March 2025

We are excited to announce that MDPI journals will participate, as exhibitors, in the 17th European Conference on Fungal Genetics (ECFG17), from 2 to 5 March 2025. The city of Dublin will welcome over 1,000 participants to this prestigious biennial event, bringing together leading researchers, academics, and professionals in the field of fungal genetics from around the globe. The conference aims to foster collaboration, share cutting-edge research, and promote advancements in the study of fungi and their genetic aspects.

Main conference topics:

  • Biodiversity and Molecular Taxonomy;
  • Evolution;
  • Cell Biology and Development;
  • Genome Function and Epigenetics;
  • Metabolism and Metabolites;
  • Sensing and Signaling;
  • Molecular Tools and Synthetic Biology;
  • Fungal interactions (Pathogens and Symbionts);
  • Antifungal compounds;
  • Fungal Biotechnology.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://ecfg17.org/.

17 December 2024
Over 100 German Universities Partner with MDPI in New National Agreement


More than 100 German universities and research institutions have entered into a national agreement with MDPI. The publication agreement negotiated by ZB MED comes into effect on 1 January 2025 and is valid until the end of 2026. Joining the consortium is still possible until the beginning of 2025. We are delighted by the high level of interest this agreement has already garnered, reflecting the strong demand for accessible and cost-effective open access publishing solutions among German research institutions.

This new cooperation aims to make scientific gold open access publishing more affordable and less administratively burdensome for researchers in Germany. The agreement includes substantial discounts on article processing charges (APCs) for corresponding authors from participating institutions. It offers flexible payment options, including centralized invoicing or individual payment of fees by researchers or their institutions. Additionally, the agreement features a flat-fee model that enables institutions to precisely plan expenses and optimize their library budgets.

"MDPI can look back on over a decade of successful partnerships with German research institutions," says Peter Roth, MDPI Head of Publishing. "The new agreement marks another milestone in the long-standing co-operation between MDPI and the German scientific community. It emphasizes our commitment to developing up-to-date and inventive solutions for the diverse needs of scientific institutions to promote open research for the benefit of researchers."

Petra Labriga, Head of Strategic License Management at ZB MED, highlighted the agreement's significance: "As one of the world's leading Gold OA publishers, MDPI plays a central role in the German publishing landscape. We are particularly pleased that we were able to achieve considerable potential cost savings for scientific institutions and their authors at a national level through our negotiations."

The partnership reflects a common goal of advancing the idea of open access and supporting researchers in making their scientific excellence internationally visible.

"We would like to thank the ZB MED consortium team for their excellent collaboration," added Adrian Stefan Zamfir, MDPI Institutional Partnership Manager for the DACH region. "We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform."

Franziska Fischer (right), Commercial Director at ZB MED, an Peter Roth (left), Head of Publishing at MDPI, celebrate the signing of the new national open access agreement between MDPI and the ZB MED Consortium.

Peter Roth (center) joined ZB MED's Lea Carolina Schindler, Petra Labriga, Franziska Fischer, and Jonathan Lehmann in Cologne, Germany, on 13 December 2024 to sign the agreement.

More Information

  • Conditions and participation opportunities (German): Link
  • Frequently asked questions (German): Link

Contact


About ZB MED

ZB MED - Information Centre for Life Sciences is an infrastructure and research centre for life science information and data. Its aim is to support and strengthen research for people and the environment: from medicine to biodiversity and environmental protection.

The work of ZB MED is orientated towards the strategic guidelines:

  • Research + Networking: We conduct research together with the regionally, nationally, European and globally networked research community.
  • Data science: We enable data analyses and generate new knowledge through research.
  • Access to information: We provide sustainable access to information, literature and data as a central information infrastructure.
  • Open + FAIR: We promote open and reproducible science in line with open science and FAIR principles.
  • Knowledge and skills transfer: We actively impart knowledge, competences and skills.

More information at www.zbmed.de.

About MDPI

Headquartered in Basel, Switzerland, MDPI is one of the world's leading open access publishers with a current portfolio of more than 440 journals in all scientific disciplines. MDPI‘s goal is to advance open science worldwide through greater transparency, efficiency and collaboration. To date, more than 3.7 million researchers have published their results in MDPI journals. The editorial process is overseen by a large network of dedicated reviewers and editors and supported by more than 6500 MDPI employees. MDPI currently works with over 800 academic institutions and 180 scientific societies worldwide, which benefit from a wide range of MDPI services and products.

17 December 2024
Article Layout and Template Revised for Future Volumes

We are pleased to announce a series of updates to our template, aimed at improving the readability and overall aesthetics of our publications. These changes have been meticulously designed to enhance the user experience and ensure consistency across all our publications. The updated template will be available for download from the Instructions for Authors page.

The following updates will be applied to articles published in the 2025 volumes, starting on 24 December 2024:

  • Main text: The line spacing has been increased to improve the readability of publications;
  • Header and footer: The link to the journal website will be removed, as a hyperlink has been integrated into the journal logo. Additionally, the DOI link will be moved from the left-hand side to the right-hand side, and both the header and footer will be slightly raised to achieve a better balance;
  • Left information bar: The information provided here has been rearranged for better organization; the CC-BY logo will be removed;
  • Font size: The font size used for the abstract, keywords, and first-level headings will be increased.

Furthermore, MDPI journals will continue to use article numbers. This approach enables us to maintain a rapid and efficient production process by being able to define pagination as soon as a paper is accepted.

We hope that the new version of the template will provide users with a better experience and make the process more convenient.

Please contact production@mdpi.com if you have any questions or suggestions.

Back to TopTop